Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Folinic Acid-d4 (Leucovorin-d4) REF: 4Z-F-068015	- - -	To inquire	Tue 10 Dec 24
Gimeracil Impurity 14 REF: 4Z-G-047016CAS: 89942-45-0	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 64 REF: 4Z-P-196071	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 44 REF: 4Z-E-068057CAS: 446-31-1	- - -	To inquire	Tue 10 Dec 24
FLTX1 REF: TM-T8984CAS: 1481401-71-1	98.42%	57.00 €~2,471.00 €	Tue 10 Dec 24
Carfilzomib Impurity 42 REF: 4Z-C-121045	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 31 REF: 4Z-E-068044	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 19 REF: 4Z-C-121022	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 79 REF: 4Z-N-066090CAS: 708279-23-6	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 44 REF: 4Z-O-032049	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 102 REF: 4Z-N-066116	- - -	To inquire	Tue 10 Dec 24
Fulvestrant S Enantiomer REF: 4Z-F-3138CAS: 1807900-80-6	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 50 REF: 4Z-E-068063	- - -	To inquire	Tue 10 Dec 24
Abiraterone Impurity 2 REF: 4Z-A-8235	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 55 REF: 4Z-C-121058CAS: 1809093-03-5	- - -	To inquire	Tue 10 Dec 24
4-Hydroxy Tamoxifen-d5 (Phenyl-ring-d5) REF: 4Z-T-0125	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 21 REF: 4Z-C-121024	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 40 REF: 4Z-C-121043CAS: 1545468-80-1	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 9 REF: 4Z-E-068022CAS: 1895865-10-7	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 32 REF: 4Z-L-124038CAS: 417714-14-8	- - -	To inquire	Tue 10 Dec 24

1mg		57.00 €
5mg		123.00 €
10mg		188.00 €
25mg		321.00 €
50mg		454.00 €
100mg		643.00 €
200mg		867.00 €

Cancer treatment

Folinic Acid-d4 (Leucovorin-d4)

Ref: 4Z-F-068015

Gimeracil Impurity 14

Ref: 4Z-G-047016

Palbociclib Impurity 64

Ref: 4Z-P-196071

Enzalutamide Impurity 44

Ref: 4Z-E-068057

FLTX1

Ref: TM-T8984

Carfilzomib Impurity 42

Ref: 4Z-C-121045

Enzalutamide Impurity 31

Ref: 4Z-E-068044

Carfilzomib Impurity 19

Ref: 4Z-C-121022

Nintedanib Impurity 79

Ref: 4Z-N-066090

Olaparib Impurity 44

Ref: 4Z-O-032049

Nintedanib Impurity 102

Ref: 4Z-N-066116

Fulvestrant S Enantiomer

Ref: 4Z-F-3138

Enzalutamide Impurity 50

Ref: 4Z-E-068063

Abiraterone Impurity 2

Ref: 4Z-A-8235

Carfilzomib Impurity 55

Ref: 4Z-C-121058

4-Hydroxy Tamoxifen-d5 (Phenyl-ring-d5)

Ref: 4Z-T-0125

Carfilzomib Impurity 21

Ref: 4Z-C-121024

Carfilzomib Impurity 40

Ref: 4Z-C-121043

Enzalutamide Impurity 9

Ref: 4Z-E-068022

Lenvatinib Impurity 32

Ref: 4Z-L-124038